Moderna, Inc.
MRNA
Xếp hạng trong cổ phiếu
#225
Moderna, Inc., a biotechnology firm, is dedicated to the discovery,... Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses like COVID-19, influenza, and respiratory syncytial virus (RSV); latent viral infections such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), herpes simplex virus (HSV), and varicella-zoster virus (VZV); and public health threats like Zika and Nipah. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions. Moderna maintains strategic alliances with several prominent entities, including AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, Carisma Therapeutics, Inc., Metagenomi, Inc., the Defense Advanced Research Projects Agency (DARPA), the Biomedical Advanced Research and Development Authority (BARDA), the Institute for Life Changing Medicines, and The Bill & Melinda Gates Foundation. It also holds a collaboration and license agreement with Chiesi Farmaceutici S.P.A. Founded in 2010 as Moderna Therapeutics, Inc., the company officially became Moderna, Inc. in August 2018. Its corporate headquarters are located in Cambridge, Massachusetts.
Giá cổ phiếu
$251.29
Đồng bộ lần cuối: 2026-10-21
Vốn hóa thị trường
$100.32B
Thay đổi (1 ngày)
3.80%
Thay đổi (1 năm)
835.90%
Quốc gia
US
Giao dịch Moderna, Inc. (MRNA)
Danh mục
Healthcare
Lịch sử giá cổ phiếu của Moderna, Inc. (MRNA)
Giá đóng cửa cao nhất: $214.61 vào 2026-10-01
Giá đóng cửa thấp nhất: $16.43 vào 2018-12-01
Giá đóng cửa thấp nhất: $16.43 vào 2018-12-01
Lịch sử giá cổ phiếu của Moderna, Inc. từ 2018 đến 2026
Hiệu suất giá cổ phiếu hàng năm
| Năm | Hiệu suất |
|---|---|
| 2026 (TTM) | 137.22% |
| 2025 | -29.03% |
| 2024 | -52.07% |
| 2023 | -53.95% |
| 2022 | -30.75% |
| 2021 | 94.33% |
| 2020 | 620.28% |
| 2019 | 18.09% |
| 2018 | 0.00% |
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
| Công ty | Giá cổ phiếu | Thay đổi 1năm% | Quốc gia |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $766.95 | 9.01% |
CH
|
|
| $260.54 | -8.46% |
BE
|
